Skip to main content
. 2017 May 17;8(40):67152–67168. doi: 10.18632/oncotarget.17934

Figure 6. Mucin copy number alterations in cancer.

Figure 6

Patients were split into cohorts with a minimum size of two for histology and stage. Supplementary Table 1 contains the full cohort names and sample sizes. Figure key color is determined by the median of the copy number, which was determined by the calculated segmean as described in methods. Heatmap color scales are depicted on the left. (A) Copy number status that deviated at least 0.5 from diploid were rounded and considered to have copy gain or loss. (B) Copy number median is displayed regardless of copy number status. (C) A table highlighting the percentage of patients with the corresponding copy number status for the region 3q29 containing MUC4 and MUC20 in LUSC and OSC. Histology, stage, and patients in the cohort are listed in the first three columns. The percent of patients in the categories are given with the following copy number statuses: deletion (Del; n = 0), copy loss (Loss; n = 1), diploid (Diploid; n = 2), copy gain (Gain; n = 3), and amplified (Amp; n = 4 or greater).